Role of postoperative radiotherapy after pelvic lymphadenectomy and radical retropubic prostatectomy: A single institute experience of 415 patients

International Journal of Radiation Oncology Biology Physics

Volumn 59, Issue 3, 2004, Pages 674-683

  Cozzarini, Cesare ^a   Bolognesi, Angelo ^a   Ceresoli, Giovanni Luca ^a   Fiorino, Claudio ^a   Rossa, Alberto ^a   Bertini, Roberto ^a   Colombo, Renzo ^a   Da Pozzo, Luigi ^a   Montorsi, Francesco ^a   Roscigno, Marco ^a   Calandrino, Riccardo ^a   Rigatti, Patrizio ^a   Villa, Eugenio ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Adjuvant radiotherapy; Prostatectomy; Prostatic neoplasms

Indexed keywords

BIOCHEMISTRY; MEDICAL IMAGING; PATHOLOGY; PATIENT TREATMENT; PROSTHETICS;

ADENOCARCINOMA; LYMPHADENECTOMY; PROSTATECTOMY;

RADIOTHERAPY;

ACUTE TOXICITY; ADULT; ADVANCED CANCER; AGED; ARTICLE; BEAM THERAPY; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER SURGERY; CHRONIC TOXICITY; CONTROLLED STUDY; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATECTOMY; SALVAGE THERAPY; TREATMENT FAILURE;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; COMBINED MODALITY THERAPY; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; PELVIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 2942590376     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.12.001     Document Type: Article

References (46)

1. Potosky A.L., Miller B.A., Albertsen P.C., et al. The role of increasing detection in the rising incidence of prostate cancer. JAMA. 273:1995;548-552
2. Amling C.L., Blute M.L., Lerner S.E., et al. Influence of prostate-specific antigen testing on the spectrum of patients with prostate cancer undergoing radical prostatectomy at a large referral practice. Mayo Clin Proc. 73:1998;401-406
3. Wieder J.A., Soloway M.S. Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer. J Urol. 160:1998;299-315
4. Cheng L., Darson M.F., Bergstralh E.J., et al. Correlation of margin status and extraprostatic extension with progression of prostate carcinoma. Cancer. 86:1999;1775-1782
5. Cheng C.W., Bergstralh E.J., Zincke H. Stage D1 prostate cancer A nonrandomized comparison of conservative treatment options versus radical prostatectomy. Cancer. 71:1993;996-1004
6. Austenfeld M.S., Davis B.E. New concepts in the treatment of stage D1 adenocarcinoma of the prostate. Urol Clin North Am. 17:1990;867-884
7. Leibovich B.C., Engen D.E., Patterson D.E., et al. Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical margin. J Urol. 163:2000;1178-1182
8. Cheng W.S., Frydenberg M., Bergstralh E.J., et al. Radical prostatectomy for pathologic stage C prostate cancer Influence of pathologic variables and adjuvant treatment on disease outcome. Urology. 42:1993;283-291
9. Ohori M., Wheeler T.M., Kattan M.W., et al. Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol. 154:1995;1818-1824
10. Anscher M.S., Robertson C.N., Prosnitz R. Adjuvant radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate Ten-year update. Int J Radiat Oncol Biol Phys. 33:1995;37-43
11. Petrovich Z., Lieskovsky G., Langholz B., et al. Postoperative radiotherapy in 423 patients with pT3N0 prostate cancer. Int J Radiat Oncol Biol Phys. 53:2002;600-609
12. Petrovich Z., Lieskovsky G., Langholz B., et al. Nonrandomized comparison of surgery with and without adjuvant pelvic irradiation for patients with pT3N0 adenocarcinoma of the prostate. Am J Clin Oncol. 24:2001;537-546
13. Schild S.E., Wong W.W., Grado G.L., et al. The result of radical retropubic prostatectomy and adjuvant therapy for pathologic stage C prostate cancer. Int J Radiat Oncol Biol Phys. 34:1996;535-541
14. Zietman A.L., Coen J.J., Shipley W.U., et al. Adjuvant irradiation after radical prostatectomy for adenocarcinoma of prostate Analysis of freedom from PSA failure. Urology. 42:1993;292-298
15. Morris M.M., Dallow K.C., Zietman A.L., et al. Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys. 38:1997;731-736
16. Valicenti R.K., Gomella L.G. Durable efficacy of adjuvant radiation therapy for prostate cancer Will the benefit last? Semin Urol Oncol. 18:2000;115-120
17. Valicenti R.K., Gomella L.G., Ismail M., et al. Effect of higher radiation dose on biochemical control after radical prostatectomy for PT3N0 prostate cancer. Int J Radiat Oncol Biol Phys. 42:1998;501-506
18. Coetzee L.J., Hars V., Paulson D.F. Postoperative prostate-specific antigen as a prognostic indicator in patients with margin-positive prostate cancer, undergoing adjuvant radiotherapy after radical prostatectomy. Urology. 47:1996;232-235
19. Romics I., Wurz U., Bach D. The prognostic value of prostate specific antigen in the follow-up of patients after radical prostatectomy. Int Urol Nephrol. 27:1995;319-324
20. Sobin LH, Wittekind CH, editors for the International Union Against Cancer (UICC). TNM classification of malignant tumours. 5th ed. New York: Wiley; 1997
21. Cozzarini C., Fiorino C., Ceresoli G.L., et al. Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6-70.2 Gy). Int J Radiat Oncol Biol Phys. 55:2003;688-694
22. Zelefsky M.J., Aschkenasy E., Kelsen S., et al. Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 39:1997;327-333
23. Cozzarini C., Fiorino C., Mandelli D., et al. 3D conformal radiotherapy significantly reduces toxicity of post-prostatectomy adjuvant of salvage irradiation [Abstract]. Int J Radiat Oncol Biol Phys. 48:(Suppl. 1):2000;248
24. Fiorino C. Set-up error for conformal radiotherapy of prostate cancer. Radiother Oncol. 56:2000;355-356
25. Marks L.B., Carroll P.R., Dugan T.C., et al. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys. 31:1995;1257-1280
26. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481
27. Cox D.R. Regression models and life tables. J Roy Stat Soc. 34:1982;187-220
28. Cadeddu J.A., Partin A.W., Epstein J.I., et al. Stage D1 (T1-3, N1-3, M0) prostate cancer A case-controlled comparison of conservative treatment versus radical prostatectomy. Urology. 50:1997;251-255
29. Steinberg G.D., Epstein J.I., Piantadosi S., et al. Management of stage D1 adenocarcinoma of the prostate The Johns Hopkins experience 1974 to 1987. J Urol. 144:1990;1425-1432
30. Catalona W.J., Smith D.S. 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol. 152:1994;1837-1842
31. Kausik S.J., Blute M.L., Sebo T.J., et al. Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomy. Cancer. 95:2002;1215-1219
32. Epstein J.I. Incidence and significance of positive margins in radical prostatectomy specimens. Urol Clin North Am. 23:1996;651-663
33. Vicini F.A., Ziaja E.L., Kestin L.L., et al. Treatment outcome with adjuvant and salvage irradiation after radical prostatectomy for prostate cancer. Urology. 54:1999;111-117
34. Choo R., Hruby G., Hong J., et al. (IN)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy. Int J Radiat Oncol Biol Phys. 53:2002;269-276
35. Suit H.D., Westgate S.J. Impact of improved local control on survival. Int J Radiat Oncol Biol Phys. 12:1986;453-458
36. Zagars G.K., von Eschenbach A.C., Ayala A.G., et al. The influence of local control on metastatic dissemination of prostate cancer treated by external beam megavoltage radiation therapy. Cancer. 68:1991;2370-2377
37. Coen J.J., Zietman A.L., Thakral H., et al. Radical radiation for localized prostate cancer Local persistence of disease results in a late wave of metastases. J Clin Oncol. 20:2002;3199-3205
38. Do T.M., Parker R.G., Smith R.B., et al. High-grade carcinoma of the prostate A comparison of current local therapies. Urology. 57:2001;1121-1126
39. Andriole G.L. Adjuvant therapy for prostate cancer patients at high risk of recurrence following radical prostatectomy. Eur Urol. 32:(Suppl. 3):1997;65-69
40. Frazier H.A., Robertson J.E., Paulson D.F. Does radical prostatectomy in the presence of positive pelvic lymph nodes enhance survival? World J Urol. 12:1994;308-312
41. Frohmuller H.G., Theiss M., Manseck A., et al. Survival and quality of life of patients with stage D1 (T1-3 pN1-2 M0) prostate cancer Radical prostatectomy plus androgen deprivation versus androgen deprivation alone. Eur Urol. 27:1995;202-206
42. Freeman J.A., Lieskovsky G., Grossfeld G., et al. Adjuvant radiation, chemotherapy, and androgen deprivation therapy for pathologic stage D1 adenocarcinoma of the prostate. Urology. 44:1994;719-725
43. Carter G.E., Lieskovsky G., Skinner D.G., et al. Results of local and/or systemic adjuvant therapy in the management of pathological stage C or D1 prostate cancer following radical prostatectomy. J Urol. 142:1989;1266-1270
44. Sidi A.A., Lange P.H. Adjuvant radiation therapy in patients upstaged to stage C or D1 disease after radical prostatectomy. Eur Urol. 13:1987;238-241
45. Bahnson R.R., Garnett J.E., Grayhack J.T. Adjuvant radiation therapy in stages C and D1 prostatic adenocarcinoma Preliminary results. Urology. 27:1986;403-406
46. Zagars G.K., Pollack A., von Eschenbach A.C. Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer. Urology. 58:2001;233-239